People with medical conditions, a history of disordered eating, diabetes medications, pregnancy, kidney disease, or complex health histories need medical oversight
One randomized, controlled trial from 2021 found that liraglutide reduced major adverse cardiovascular events, including cardiovascular death, non-fatal myocardial infarction and non-fatal stroke, by 13 percent compared to placebo in patients with type 2 diabetes at high cardiovascular risk
Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., & Jensen, M
We explain why researchers include this ingredient in study formulas
Eating large volumes or very rich foods may exacerbate gastrointestinal discomfort
Continuing education is necessary to ensure evolving evidence reaches people living with type 2 diabetes